NCT06086392View on ClinicalTrials.gov

Perineural Dexamethasone in Supraclavicular Brachial Plexus Block for Anesthesia After Pediatric Hand/Wrist Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 17, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

July 11, 2025

Conditions
Wrist DiseaseHand InjuriesWrist InjuriesHand DiseaseHand Injuries and Disorders
Interventions
DRUG

Placebo

administration of 0.5ml/kg of 0,2% ropivacaine + 0.01ml/kg 0.9% sodium chloride for the supraclavicular brachial plexus block

DRUG

0.1mg/kg Dexamethasone

administration of 0.5ml/kg of 0.2% ropivacaine with 0.1mg/kg Dexamethasone for the supraclavicular brachial plexus block

DRUG

0.05mg/kg Dexamethasone

administration of 0.5ml/kg of 0,2% ropivacaine with 0.05mg/kg Dexamethasone for the supraclavicular brachial plexus block

Trial Locations (1)

61-701

Poznan University of Medical Sciences, Skórzewo

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06086392 - Perineural Dexamethasone in Supraclavicular Brachial Plexus Block for Anesthesia After Pediatric Hand/Wrist Surgery | Biotech Hunter | Biotech Hunter